Stay updated on Selinexor Combo for High-Risk Myeloma Clinical Trial

Sign up to get notified when there's something new on the Selinexor Combo for High-Risk Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selinexor Combo for High-Risk Myeloma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A notice about NIH’s terminology transition appears near the top of the page, linking to updates and FAQs.
    Difference
    0.6%
    Check dated 2026-10-24T22:06:18.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer now identifies the platform as revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-17T20:51:08.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-10T21:45:08.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The latest version adds Results Posted, Adverse Events, and Outcome Measures (Results) along with an updated Study Status and revision v3.7.0. Previously listed items like Results Submitted and Revision: v3.6.6 have been removed, indicating a transition from submission to public posting of trial results.
    Difference
    0.7%
    Check dated 2026-09-19T20:14:09.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The revision history now shows a new entry for v3.6.6 and removes the previous v3.6.5 entry, updating the page's revision log to reflect the latest version.
    Difference
    0.1%
    Check dated 2026-08-29T19:47:56.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The record history now shows a new revision (v3.6.5) returned on 2026-07-31, bringing in newly surfaced sections such as Adverse Events, Baseline Characteristics, Participant Flow, Outcome Measures (Results), Study Design, and Study Status to the study record. This update broadens the displayed data and status details for the trial.
    Difference
    1%
    Check dated 2026-08-08T17:59:11.000Z thumbnail image

Stay in the know with updates to Selinexor Combo for High-Risk Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selinexor Combo for High-Risk Myeloma Clinical Trial page.